You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Standard dose radiotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT, induction chemo, cisplatin concurrent chemo)

Recruiting
  • Nasopharyngeal Carcinoma
  • IMRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Universitty Cancer Center
May 5, 2022

Esophageal Cancer Trial in Shantou (Radiotherapy with simultaneous modulated accelerated boost, Standard dose radiotherapy, PF)

Recruiting
  • Esophageal Cancer
  • Radiotherapy with simultaneous modulated accelerated boost
  • +2 more
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Dec 27, 2021

Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • DE-HyART
  • +3 more
  • Delhi, India
    Rajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023

Heel Spur Trial in Brno (Standard fractioned dose, Experimental single dose)

Recruiting
  • Heel Spur
  • Standard fractioned dose
  • Experimental single dose
  • Brno, Czechia
    Masaryk Memorial Cancer Institute
Oct 30, 2023

Palliative Radiotherapy Trial in Saint Leonards (dose escalation)

Recruiting
  • Palliative Radiotherapy
  • dose escalation
  • Saint Leonards, New South Wales, Australia
    Royal North Shore Hospital
Oct 25, 2022

Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1

Recruiting
  • Nasopharyngeal Carcinoma
  • De-escalation Therapy
  • Cisplatin-based induction chemotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 16, 2023

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Standard systemic therapy + radiotherapy
  • Standard systemic therapy
  • Gothenburg, Sweden
  • +5 more
Nov 17, 2023

Cancer of Rectum Trial in Denmark (50.4 Gy to the tumor and elective volume, 62 Gy to the clinical tumor volume and 50.4 Gy to

Recruiting
  • Cancer of Rectum
  • 50.4 Gy to the tumor and elective volume
  • +2 more
  • Aalborg, Denmark
  • +4 more
May 24, 2022

Cervical Cancer Trial in Kelowna, London, Toronto (External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy

Recruiting
  • Cervical Cancer
  • External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Experimental
  • +2 more
  • Kelowna, British Columbia, Canada
  • +2 more
Apr 12, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Miami (Standard Salvage Radiation Treatment (SSRT), Mapped Tumor Salvage RT

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Standard Salvage Radiation Treatment (SSRT)
  • Mapped Tumor Salvage RT (MTSRT)
  • Miami, Florida
    University of Miami
Dec 1, 2021

Glioblastoma Trial in France, Portugal, Spain ([177Lu]Lu-DOTA-TATE, [68Ga]Ga-DOTA-TATE, Temozolomide)

Recruiting
  • Glioblastoma
  • Bron, France
  • +8 more
Jan 23, 2023

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Larynx Trial (Hypofractionated

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Hypofractionated Postoperative Radiotherapy
  • (no location specified)
Sep 12, 2022

Stage IV NSCLC Trial in Palo Alto (Immunotherapy (physician's choice for standard of care immunotherapy), Image-guided Radiation

Active, not recruiting
  • Stage IV Non-Small Cell Lung Cancer
  • Immunotherapy (physician's choice for standard of care immunotherapy)
  • Image-guided Radiation Therapy
  • Palo Alto, California
    Stanford University, School of Medicine
Aug 17, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Miami (Lattice Extreme Ablative Dose Radiation Therapy, Standard IMRT)

Completed
Has Results
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Lattice Extreme Ablative Dose Radiation Therapy
  • Standard IMRT
  • Miami, Florida
    University of Miami
Jul 11, 2021

Prostate Cancer Trial in St Leonards (Dose escalation using stereotactic boost)

Completed
  • Prostate Cancer
  • Dose escalation using stereotactic boost
  • St Leonards, New South Wales, Australia
    Northern Sydney Cancer Centre, Royal North Shore Hospital
Jun 10, 2021

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Intensity-modulated radiation therapy, Paclitaxel liposome, Cisplatin)

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • Intensity-modulated radiation therapy
  • +3 more
  • Guangzhou, Guangdong, China
    Hai Qiang Mai
Aug 23, 2021

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)

Recruiting
  • Cancer Patients
  • Low-dose radiotherapy combined with conventional fractionated radiotherapy
  • Jinan, In Shandong Province, China
    The First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023

Primary Non-operated Squamous Cell Carcinoma of Oral Cavity, Primary Non-operated Squamous Cell Carcinoma of Oropharynx, Primary

Active, not recruiting
  • Primary Non-operated Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Adaptive dose-painting-by-numbers
  • standard intensity-modulated radiotherapy (IMRT)
  • Ghent, Belgium
  • +1 more
Feb 16, 2021

Prostatic Tumors Trial (Prostate SBRT with Focal Boost, Triptorelin Injection)

Not yet recruiting
  • Prostatic Neoplasms
  • Prostate SBRT with Focal Boost
  • Triptorelin Injection
  • (no location specified)
May 1, 2023

Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)

Not yet recruiting
  • Prostate Cancer
  • Radiotherapy standard
  • Radiotherapy Hypo-FLAME
  • (no location specified)
Jan 30, 2023

Head and Neck Squamous Cell Carcinoma, Hypofractionation, Radiotherapy Trial (HYpofractionated, Dose-redistributed RAdiotherapy

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA)
  • conventional fractionated radiotherapy
  • Rotterdam, Zuid Holland, Netherlands
    Erasmus MC
Dec 7, 2022